Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4476
AllianzIM U.S. Equity 6 Month Buffer10 Apr/Oct ETF
SIXO
$118M
| $54.9K | ﹤0.01% |
1,498
| – | – |
2026 Q2
1 quarter
|
|
4477
AN2 Therapeutics
ANTX
$151M
| $54.8K | ﹤0.01% |
10,305
+4,814
| +88% | +$25.5K |
2026 Q1
2 quarters
|
|
4478
Nano X Imaging
NNOX
$18.9M
| $54.7K | ﹤0.01% |
78,922
-67,892
| -46% | -$62.6K |
2022 Q1
18 quarters
|
|
4479
Global Self Storage
SELF
$55.3M
| $54.5K | ﹤0.01% |
11,105
+527
| +5% | +$2.73K |
2026 Q1
2 quarters
|
|
4480
Daqo New Energy
DQ
$856M
| $54.2K | ﹤0.01% |
4,744
+4,294
| +954% | +$54.3K |
2020 Q2
25 quarters
|
|
4481
Bally's
BALY
$625M
| $54.2K | ﹤0.01% |
3,947
+2,373
| +151% | +$28.6K |
2025 Q2
5 quarters
|
|
4482
Artiva Biotherapeutics
ARTV
$203M
| $54K | ﹤0.01% |
7,588
+4,252
| +127% | +$42.9K |
2026 Q2
1 quarter
|
|
4483
TIM SA
TIMB
$8.62B
| $54K | ﹤0.01% |
3,025
+1,066
| +54% | +$20.6K |
2024 Q4
7 quarters
|
|
4484
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.84B
| $53.9K | ﹤0.01% |
1,000
| – | – |
2022 Q3
16 quarters
|
|
4485
Pro-Dex
PDEX
$202M
| $53K | ﹤0.01% |
768
+463
| +152% | +$29.6K |
2025 Q2
5 quarters
|
|
4486
FT Vest US Equity Buffer ETF October
FOCT
$1.25B
| $52.6K | ﹤0.01% |
972
| – | – |
2025 Q1
6 quarters
|
|
4487
MoonLake Immunotherapeutics
MLTX
$981M
| $52.5K | ﹤0.01% |
4,490
-7,418
| -62% | -$121K |
2023 Q3
12 quarters
|
|
4488
BRT Apartments
BRT
$236M
| $52.3K | ﹤0.01% |
3,917
-8,539
| -69% | -$124K |
2017 Q4
35 quarters
|
|
4489
Advantage Solutions
ADV
$403M
| $52.3K | ﹤0.01% |
2,014
+1,230
| +157% | +$42.9K |
2022 Q1
18 quarters
|
|
4490
SR Bancorp
SRBK
$138M
| $52.2K | ﹤0.01% |
2,769
+1,702
| +160% | +$33.3K |
2025 Q2
5 quarters
|
|
4491
EverCommerce
EVCM
$1.45B
| $52K | ﹤0.01% |
6,009
+2,936
| +96% | +$28.5K |
2022 Q1
18 quarters
|
|
4492
Innovator US Equity Buffer ETF July
BJUL
$350M
| $51.8K | ﹤0.01% |
935
+898
| +2,427% | +$49.4K |
2026 Q2
1 quarter
|
|
4493
Claros Mortgage Trust
CMTG
$231M
| $51.7K | ﹤0.01% |
41,388
+21,833
| +112% | +$39.5K |
2022 Q2
17 quarters
|
|
4494
KLX Energy Services
KLXE
$105M
| $51.7K | ﹤0.01% |
35,679
+34,036
| +2,072% | +$63.3K |
2023 Q1
14 quarters
|
|
4495
US GoldMining
USGO
$73.5M
| $51.6K | ﹤0.01% |
7,750
+7,418
| +2,234% | +$60.5K |
2025 Q2
5 quarters
|
|
4496
KULR Technology Group
KULR
$68.5M
| $51.6K | ﹤0.01% |
20,383
-4,670
| -19% | -$12.7K |
2025 Q2
5 quarters
|
|
4497
Aemetis
AMTX
$117M
| $51.5K | ﹤0.01% |
28,948
+13,739
| +90% | +$24.2K |
2023 Q3
12 quarters
|
|
4498
GrafTech
EAF
$258M
| $51.3K | ﹤0.01% |
6,208
+2,398
| +63% | +$17.5K |
2018 Q2
33 quarters
|
|
4499
CAMP4 Therapeutics
CAMP
$255M
| $51.3K | ﹤0.01% |
12,700
+5,604
| +79% | +$23K |
2025 Q3
4 quarters
|
|
4500
FT Vest U.S. Equity Quarterly 2.5 to 15 Buffer ETF
DHDG
$77.2M
| $51.1K | ﹤0.01% |
1,356
| – | – |
2025 Q4
3 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.